Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genome- |
RCV001250622 | SCV001810377 | pathogenic | Leber congenital amaurosis 8 | 2021-07-22 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002549197 | SCV003524000 | pathogenic | Retinitis pigmentosa 12; Leber congenital amaurosis 8 | 2023-10-07 | criteria provided, single submitter | clinical testing | This sequence change affects a donor splice site in intron 11 of the CRB1 gene. While this variant is not anticipated to result in nonsense mediated decay, it likely alters RNA splicing and results in a disrupted protein product. This variant is present in population databases (no rsID available, gnomAD 0.006%). Disruption of this splice site has been observed in individual(s) with clinical features of CRB1-related conditions (PMID: 15024725, 20683928, 23379534, 31456290). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 812303). Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. |
Baylor Genetics | RCV001250622 | SCV004211217 | pathogenic | Leber congenital amaurosis 8 | 2023-12-14 | criteria provided, single submitter | clinical testing | |
Sharon lab, |
RCV001003000 | SCV001161054 | pathogenic | Leber congenital amaurosis | 2019-06-23 | no assertion criteria provided | research | |
Laboratory of Genetics in Ophthalmology, |
RCV001250622 | SCV001425492 | pathogenic | Leber congenital amaurosis 8 | no assertion criteria provided | research |